Companies /Healthcare
Phathom Pharmaceuticals Inc
NASDAQ: PHAT Biotechnology
$7.13
▲ $0.32 (+4.70%) today
Markets closed · 6:22pm ET

Phathom Pharmaceuticals (PHAT) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
83%
EPS beat rate
+29.44%
Avg. EPS surprise
Consecutive EPS beats
PHAT vs Market · 30-day return after each reportPHATS&P 500
−20%0%+20%+40%+47.3%+6.7%Q1 25+37.1%+2.9%Q2 25+10.7%+0.3%Q3 25−22.4%−8.3%Q4 25−13.8%+5.7%Q1 26+6.0%+3.4%Q2 26
−20%0%+20%+40%Q1 25Q3 25Q1 26
PHAT EPS Trend · estimate vs actualEstimateActual
$-1.20$-0.80$-0.40$0.00$-1.07$-1.07Q1 25$-0.89$-0.79Q2 25$-0.42$-0.41Q3 25$-0.19$-0.08Q4 25$-0.19$-0.18Q1 26$-0.10$0.00Q2 26
$-1.20$-0.80$-0.40$0.00Q1 25Q3 25Q1 26
PHAT Revenue Trend · estimate vs actualEstimateActual
$0$30.0M$60.0M$29.0M$28.5MQ1 25$35.6M$39.5MQ2 25$47.0M$49.5MQ3 25$57.4M$57.6MQ4 25$56.8M$58.3MQ1 26$72.7M$74.3MQ2 26
$0$30.0M$60.0MQ1 25Q3 25Q1 26

How Often Does Phathom Pharmaceuticals Beat Earnings Estimates?

Phathom Pharmaceuticals beat EPS estimates in 5 of its last 6 reported quarters, and has beaten 5 quarters in a row.

PHAT quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q2 2026 $0.00 est. $-0.10 +100.00% $74.3M est. $72.7M +2.18%
Q1 2026 $-0.18 est. $-0.19 +7.36% $58.3M est. $56.8M +2.63%
Q4 2025 $-0.08 est. $-0.19 +57.45% $57.6M est. $57.4M +0.24%
Q3 2025 $-0.41 est. $-0.42 +1.20% $49.5M est. $47.0M +5.34%
Q2 2025 $-0.79 est. $-0.89 +10.99% $39.5M est. $35.6M +11.02%
Q1 2025 $-1.07 est. $-1.07 −0.38% $28.5M est. $29.0M −1.71%

Figures from SEC filings and company reports. Not investment advice.